Английская Википедия:CoCo Therapeutics
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox company
CoCo Therapeutics is a United Kingdom-based biotechnology company formed in 2013 jointly by King's College London, the Wellcome Trust and Advent Venture Partners.[1] The company will focus on development of therapeutics for Alzheimer's disease which target retinoic acid receptor alpha,[1] specifically building on work originating in the Neuroscience Drug Discovery Unit of King's College, led by Jonathan Corcoran.[2] This work was funded through the Wellcome Trust's Seeding Drug Discovery Initiative.[3]
References
Категории:
- Английская Википедия
- Biotechnology companies established in 2013
- Biotechnology companies of the United Kingdom
- 2013 establishments in the United Kingdom
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
- Страницы с ошибками в примечаниях